Literature DB >> 18551863

Management of hypomagnesemia in cancer patients receiving chemotherapy.

Muhammad Wasif Saif1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18551863

Source DB:  PubMed          Journal:  J Support Oncol        ISSN： 1544-6794


× No keyword cloud information.
  10 in total

1.  Continuous magnesium infusions in the management of systemic anti-cancer therapy-related hypomagnesaemia.

Authors:  Hector Mateo-Carrasco; Oluwakemi Kostrzynski; Onyinye Ndefo; Simon Stapley; Elaine Davies; Roshan Agarwal
Journal:  Int J Clin Pharm       Date:  2017-04-25

Review 2.  Management of locally advanced and metastatic colon cancer in elderly patients.

Authors:  Peter C Kurniali; Borys Hrinczenko; Anas Al-Janadi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 3.  Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents.

Authors:  Andreia Costa; Sabine Tejpar; Hans Prenen; Eric Van Cutsem
Journal:  Target Oncol       Date:  2011-11-24       Impact factor: 4.493

4.  Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists.

Authors:  T Thangarasa; J Gotfrit; R A Goodwin; P A Tang; M Clemons; A Imbulgoda; M M Vickers
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

5.  Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.

Authors:  Joanna Streb; Miroslawa Püsküllüoğlu; Izabela Glanowska; Sebastian Ochenduszko; Kamil Konopka; Radoslaw Łupkowski; Anna Michalowska-Kaczmarczyk; Justyna Bochenek-Cibor; Marcin Majka; Krzysztof Krzemieniecki
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

6.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

Review 7.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

8.  Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trial.

Authors:  Arif Awan; Bassam Basulaiman; Carol Stober; Mark Clemons; Dean Fergusson; John Hilton; Waleed Al Ghareeb; Rachel Goodwin; Mohammed Ibrahim; Brian Hutton; Lisa Vandermeer; Ranjeeta Mallick; Michael M Vickers
Journal:  Health Sci Rep       Date:  2021-12-14

Review 9.  Clinical potential of necitumumab in non-small cell lung carcinoma.

Authors:  Carlo Genova; Fred R Hirsch
Journal:  Onco Targets Ther       Date:  2016-08-31       Impact factor: 4.147

10.  Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab.

Authors:  Tomohiro Enokida; Shinya Suzuki; Tetsuro Wakasugi; Tomoko Yamazaki; Susumu Okano; Makoto Tahara
Journal:  Front Oncol       Date:  2016-09-14       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.